van Herck, I. G. M., Seutin, V., Bentzen, B. H., Marrion, N. V., & Edwards, A. G. (2023). Gating kinetics and pharmacological properties of small conductance calcium-activated potassium channels. Biophysical Journal. doi:10.1016/j.bpj.2023.02.004 |
Porquet, F., Weidong, L., Jehasse, K., Gazon, H., Kondili, M., Blacher, S., Massotte, L., Di Valentin, E., Furling, D., Gillet, N., Klein, A. F., Seutin, V., & Willems, L. (2023). Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy: Nucleic Acids, 32, 857 - 871. doi:10.1016/j.omtn.2023.05.007 |
Jehasse, K., Massotte, L., Hartmann, S., Vitello, R., Ringlet, S., Vitello, M., Chua, H. C., Pless, S., Engel, D., Liégeois, J.-F., Lakaye, B., Roeper, J., & Seutin, V. (01 October 2021). The gating pore blocker 1-(2,4-xylyl)guanidinium selectively inhibits pacemaking of midbrain dopaminergic neurons. Neuropharmacology, 197, 1-15. doi:10.1016/j.neuropharm.2021.108722 |
Jehasse, K., Jacquerie, K., de Froidmont, A., Lemoine, C., Grisar, T., Stouffs, K., Lakaye, B., & Seutin, V. (2021). Functional analysis of the F337C mutation in the CLCN1 gene associated with dominant myotonia congenita reveals an alteration of the macroscopic conductance and voltage dependence. Molecular Genetics and Genomic Medicine, 1588. doi:10.1002/mgg3.1588 |
Seutin, V. (2021). Electrophysiological Quality Control of Human Dopaminergic Neurons: Are We Doing Enough? Frontiers in Cellular Neuroscience, 15, 715273. doi:10.3389/fncel.2021.715273 |
Koulchitsky, S., Delairesse, C., Beeken, T., Monteforte, A., Dethier, J.-C., Quertemont, E., Findeisen, R., Bullinger, E., & Seutin, V. (26 April 2016). Activation of D2 autoreceptors alters cocaine-induced locomotion and slows down local field oscillations in the rat ventral tegmental area. Neuropharmacology, 108, 120-127. doi:10.1016/j.neuropharm.2016.04.034 |
Marx, B., Scuvee, E., Scuvée-Moreau, J., Seutin, V., & Jouret, F. (2016). Mecanismes de l'effet diuretique de la cafeine. MS. Medecine Sciences, 32 (5), 485-90. doi:10.1051/medsci/20163205015 |
Philippart, F., Destreel, G., Merino-Sepulveda, P., Henny, P., Engel, D.* , & Seutin, V.*. (2016). Differential somatic Ca2+ channel profile in midbrain dopaminergic neurons. Journal of Neuroscience, 36 (27), 7234-7245. doi:10.1523/JNEUROSCI.0459-16.2016 * These authors have contributed equally to this work. |
Saadan, M., Scuvée-Moreau, J., & Seutin, V. (June 2013). Principes du traitement pharmacologique de l'addiction. Revue Médicale de Liège, 68 (5-6), 245-251. |
Franci, A.* , Drion, G.* , Seutin, V., & Sepulchre, R. (2013). A Balance Equation Determines a Switch in Neuronal Excitability. PLoS Computational Biology, 9, 1003040. doi:10.1371/journal.pcbi.1003040 * These authors have contributed equally to this work. |
Drion, G.* , Franci, A.* , Seutin, V., & Sepulchre, R. (August 2012). A novel phase portrait for neuronal excitability. PLoS ONE, 7 (8). doi:10.1371/journal.pone.0041806 * These authors have contributed equally to this work. |
Drion, G., Massotte, L., Sepulchre, R., & Seutin, V. (2011). How modeling can reconcile apparently discrepant experimental results: the case of pacemaking in dopaminergic neurons. PLoS Computational Biology, 7 (5), 1002050. doi:10.1371/journal.pcbi.1002050 |
Scheen, A., Seutin, V., & Van Gaal, L. F. (2008). Le système endocannabinoïde dans le cerveau... et ailleurs. Revue Médicale de Liège, 63 (5-6), 364-71. |
Seutin, V., Verbanck, P., Massotte, L., & Dresse, A. (23 April 1990). Evidence for the presence of N-methyl-D-aspartate receptors in the ventral tegmental area of the rat : an electrophysiological in vitro study. Brain Research, 514 (1), 147-150. doi:10.1016/0006-8993(90)90448-K |
Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique. |
Malchair, P., Van Overmeire, L., Boland, A., Salmon, E., Pierard, L., & Seutin, V. (2005). Le coenzyme Q10: biochimie, physiopathologie de sa carence et interet potentiel d'une augmentation de ses apports. Revue Médicale de Liège, 60 (1), 45-51. |
Seutin, V. (2003). Effets de la nicotine et du cannabis sur le systeme nerveux central. Revue Médicale de Liège, 58 (1), 19-21. |
Scuvée-Moreau, J., & Seutin, V. (March 2001). Progres recents dans la pharmacologie des hypnotiques et anxiolytiques. Revue Médicale de Liège, 56 (3), 159-64. |
Rouchet, N., Waroux, O., Alix, P., Scuvée-Moreau, J., Liégeois, J.-F., & Seutin, V. (17 May 2008). SK Channel blockade promotes bursting in vivo in dorsal raphe serotonergic neurons. Acta Physiologica, 194 (supll. 666), 01. |
Hmaied, C., Koulchitsky, S., Gladwyn-Ng, I., & Seutin, V. (2020). Ketamine selectively enhances AMPA neurotransmission onto a subgroup of identified serotoninergic neurons of the rat dorsal raphe. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314508. doi:10.1101/2020.08.19.255794 |